Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 204

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Evidence for Increased Dopaminergic and Opioid Activity in Patients with Hypothalamic Hypogonadotropic Amenorrhea*

QUIGLEY, M. E., SHEEHAN, K. L., CASPER, R. F., YEN, S. S. C. · 1980 · The Journal of Clinical Endocrinology & Metabolism

Abstract

To gain insight into the psychoneuroendocrine basis for the reduced gonadotropin secretion in the hypothalamic hypogonadotropic amenorrhea syndrome, the roles of endogenous opioids and dopamine (DA) on gonadotropin and PRL release were evaluated. Responses of LH, FSH, and PRL to a DA receptor antagonist [metoclopramide (MCP); 10 mg, iv] and to an opioid receptor antagonist (naloxone infusion; 1.6 mg/h for 4 h) were analyzed in eight patients and compared with identical studies carried out in nine normal women during the low estrogen phase of the cycle. Neither MCP administration nor the naloxone infusion induced any changes in serum gonadotropinlevels in normal women. In contrast, four of eight patients responded to both receptor antagonistswith a significant increase in LH levels. The LH increment elicited by naloxone exhibited an amplification of the pulsatile pattern of release, suggesting hypothalamic LRF mediation. The other four patients with prepubertal levels of basal LH and lower concentrations of PRL and estradiol failed to show LH increments in response to either receptor antagonist. There were no significant FSH changes under these experimental conditions. Mean basal PRL concentrations were lower (P < 001) and the acute rise in PRL levels induced by MCP were smaller (P < 0.05) in all eight patients compared to those seen in normalsubjects. While the four LH responders and the normal womenexhibited no change in PRL levels during the naloxone infusion, a remarkable 100% rise in PRL was observed in the four LH nonresponders. These data suggest that at least two distinguishableforms of hypothalamic dysfunction exist in these patients; one exhibited LH increments after both opioid and DA antagonists but no PRL change in response to naloxone, and the other showed no LH increment after either receptor antagonist but did exhibit an unequivocal increase in PRL in response to naloxone. The former group may reflect an alteration of the opiate-DA system, while the latter may represent either a more severe form of the same syndrome or a distinct neuroendocrine aberration of gonadotropin and PRL secretion.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jcem-50-5-949

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 204

Metadata

Authors
QUIGLEY, M. E., SHEEHAN, K. L., CASPER, R. F., & YEN, S. S. C.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
1980-05
Volume
50
Issue
5
Pages
949-954
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2083111940
Cited by
204
References
3
FWCI
11.03
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evidence for Increased Dopaminergic and Opioid Activity in Patients with Hypothalamic Hypogonadotropic Amenorrhea*. https://app.cochat.ai/papers/10.1210/jcem-50-5-949
The paper
QUIGLEY, M. E., SHEEHAN, K. L., CASPER, R. F., & YEN, S. S. C. (1980). Evidence for Increased Dopaminergic and Opioid Activity in Patients with Hypothalamic Hypogonadotropic Amenorrhea*. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem-50-5-949

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.